Agios Pharmaceuticals (AGIO) Capital Expenditures (QoQ) (2012 - 2026)
Agios Pharmaceuticals (AGIO) Capital Expenditures (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,550.94% |
| Dec 31, 2025 | 95.94% |
| Sep 30, 2025 | -249.14% |
| Jun 30, 2025 | 14.23% |
| Mar 31, 2025 | -52.83% |
| Dec 31, 2024 | 8,447.37% |
| Sep 30, 2024 | -54.76% |
| Dec 31, 2023 | 12,212.50% |
| Sep 30, 2023 | 102.04% |
| Jun 30, 2023 | -198.50% |
| Mar 31, 2023 | 108.66% |
| Dec 31, 2022 | -196.91% |
| Sep 30, 2022 | 270.32% |
| Jun 30, 2022 | -199.61% |
| Mar 31, 2022 | -37.72% |
| Dec 31, 2021 | 280.56% |
| Sep 30, 2021 | 223.74% |
| Jun 30, 2021 | -194.47% |
| Mar 31, 2021 | 107.74% |
| Dec 31, 2020 | -231.80% |